|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 损伤控制外科的进展显示文摘 | 高劲谋 | 2006 | 中华创伤杂志2006，22，5： | 126 |
| 2 | 日间手术的概念和基本问题显示文摘 | 安燚 王振军 | 2007 | 中国实用外科杂志2007，27，1： | 236 |
| 3 | 快速康复外科的新理念值得重视显示文摘快速康复外科(fast—track surgery,FTS)是指为了加快择期手术患者术后恢复、减少术后并发症的发生、降低患者病死率及缩短住院时间而采取的一系列围手术期多学科技术综合运用措施,主要包括快速通道麻醉(fast—track anesthesia,FTA)、微创技术(MIS)、最佳镇痛技术及强有力的术后护理(如术后早期进食、运动)等。FTS是一种新的外科理念,其实质是利用现有手段将围手术期各种常规治疗措施加以改良并重新进行优化、组合。FTS的内容涉及多学科领域,并非外科学的独立分支,而是对传统外科学的重要补充与完善。FTS的宗旨是为患者提供最优质的服务、最大的益处和最少的损伤。虽然外科界关于FTS的内涵和延伸仍然存在着分歧,但正是争议和讨论才使得FTS能够不断地被重视以及丰富与发展。 | 姜洪池 孙备 王刚 | 2007 | 中华外科杂志2007，45，9： | 127 |
| 4 | 快速康复外科的现状与展望显示文摘 | 孙涛 傅卫 | 2007 | 中国微创外科杂志2007，7，6： | 97 |
| 5 | 腹壁无瘢痕手术:从NOTES到TUES显示文摘 | 朱江帆 | 2007 | 中国微创外科杂志2007，7，9： | 117 |
| 6 | 中国骨科大手术静脉血栓栓塞症预防指南显示文摘 | 邱贵兴 | 2009 | 中华关节外科杂志(电子版)2009，3，3： | 408 |
| 7 | 膝关节评分标准显示文摘常用的膝关节评分标准(kneescore)包括Lysholm评分、美国膝关节协会评分(American knee society knee score,AKS评分)、美国特种外科医院膝关节评分(hospital for special surgery knee score,HSS评分)、国际膝关节文献委员会膝关节评估表(the international knee documentation committee knee uation form,IKDC评分)。 | 严广斌 | 2010 | 中华关节外科杂志(电子版)2010，4，6： | 116 |
| 8 | 快速康复外科的现状分析与前景展望显示文摘快速康复外科(fast-track surgery,FTS)也称“促进术后恢复综合方案”(enhanced recovery after surgery,ERAS),是指采用有循证医学证据的一系列围手术期优化措施,以阻断或减轻机体的应激反应,促进患者术后尽快康复。因其可明显改善外科患者预后,显著加速术后康复进程,FTS目前在欧美国家备受推崇,极可能与当年的微创外科理念一样, | 程黎阳 | 2012 | 实用医学杂志2012，28，1： | 82 |
| 9 | 中国加速康复外科围手术期管理专家共识(2016)显示文摘一、前言 加速康复外科(enhanced recovery after surgery,ERAS)指为使患者快速康复,在围手术期采用一系列经循证医学证据证实有效的优化处理措施,以减轻患者心理和生理的创伤应激反应,从而减少并发症,缩短住院时间,降低再人院风险及死亡风险,同时降低医疗费用. | | 2016 | 中华外科杂志2016，54，6： | 797 |
| 10 | 日间手术麻醉专家共识显示文摘日间手术(Ambulatory Surgery/Day Surgery)的概念最早由英格兰的Nicoll医师提出,随着国际日间手术协会(The International Association of Ambulatory Surgery,IAAS)成立,日间手术已发展成为一种较成熟的手术管理模式。 | 欧阳文 李天佐 周星光 | 2016 | 临床麻醉学杂志2016，32，10： | 139 |
| 11 | The Chinese Society of Clinical Oncology(CSCO):clinical guidelines for the diagnosis and treatment of gastric cancer显示文摘China is one of the countries with the highest incidence of gastric cancer.There are differences in epidemiological characteristics,clinicopathological features,tumor biological characteristics,treatment patterns,and drug selection between gastric cancer patients from the Eastern and Western countries.Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients.The Chinese Society of Clinical Oncology(CSCO)arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile,discuss,and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad.By referring to the opinions of industry experts,taking into account of regional differences,giving full consideration to the accessibility of diagnosis and treatment resources,these experts have conducted experts’consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes.This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis,comprehensive treatment,and follow-up visits for gastric cancer. | Feng-Hua Wang Lin Shen Jin Li Zhi-Wei Zhou Han Liang Xiao-Tian Zhang Lei Tang Yan Xin Jing Jin Yu-Jing Zhang Xiang-Lin Yuan Tian-Shu Liu Guo-Xin Li Qi Wu Hui-Mian Xu Jia-Fu Ji Yuan-Fang Li Xin Wang Shan Yu Hao Liu Wen-Long Guan Rui-Hua Xu | 2019 | Cancer Communications2019，39，1： | 127 |
| 12 | The Chinese Society of Clinical Oncology(CSCO):Clinical guidelines for the diagnosis and treatment of gastric cancer,2021显示文摘There exist differences in the epidemiological characteristics,clinicopathological features,tumor biological characteristics,treatment patterns,and drug selections between gastric cancer patients from the Eastern and Western countries.The Chinese Society of Clinical Oncology(CSCO)has organized a panel of senior experts specializing in all sub-specialties of gastric cancer to compile a clinical guideline for the diagnosis and treatment of gastric cancer since 2016 and renews it annually.Taking into account regional differences,giving full consideration to the accessibility of diagnosis and treatment resources,these experts have conducted expert consensus judgment on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes in China.The 2021 CSCO Clinical Practice Guidelines for Gastric Cancer covers the diagnosis,treatment,follow-up,and screening of gastric cancer.Based on the 2020 version of the CSCO Chinese Gastric Cancer guidelines,this updated guideline integrates the results ofmajor clinical studies from China and overseas for the past year,focused on the inclusion of research data from the Chinese population for more personalized and clinically relevant recommendations.For the comprehensive treatment of non-metastatic gastric cancer,attentions were paid to neoadjuvant treatment.The value of perioperative chemotherapy is gradually becoming clearer and its recommendation level has been updated.For the comprehensive treatment of metastatic gastric cancer,recommendations for immunotherapy were included,and immune checkpoint inhibitors fromthird-line to the first-line of treatment for different patient groups with detailed notes are provided. | Feng-Hua Wang Xiao-Tian Zhang Yuan-Fang Li Lei Tang Xiu-Juan Qu Jie-Er Ying Jun Zhang Ling-Yu Sun Rong-Bo Lin Hong Qiu Chang Wang Miao-Zhen Qiu Mu-Yan Cai QiWu Hao Liu Wen-Long Guan Ai-Ping Zhou Yu-Jing Zhang Tian-Shu Liu Feng Bi Xiang-Lin Yuan Sheng-Xiang Rao Yan Xin Wei-Qi Sheng Hui-Mian Xu Guo-Xin Li Jia-Fu Ji Zhi-Wei Zhou Han Liang Yan-Qiao Zhang Jing Jin Lin Shen Jin Li Rui-Hua Xu | 2021 | Cancer Communications2021，41，8： | 97 |
| 13 | Treatment of gastric cancer显示文摘The authors focused on the current surgical treatment of resectable gastric cancer,and significance of periand post-operative chemo or chemoradiation.Gastric cancer is the 4thmost commonly diagnosed cancer and the second leading cause of cancer death worldwide.Surgery remains the only curative therapy,while perioperative and adjuvant chemotherapy,as well as chemoradiation,can improve outcome of resectable gastric cancer with extended lymph node dissection.More than half of radically resected gastric cancer patients relapse locally or with distant metastases,or receive the diagnosis of gastric cancer when tumor is disseminated;therefore,median survival rarely exceeds12 mo,and 5-years survival is less than 10%.Cisplatin and fluoropyrimidine-based chemotherapy,with addition of trastuzumab in human epidermal growth factor receptor 2 positive patients,is the widely used treatment in stageⅣpatients fit for chemotherapy.Recent evidence supports the use of second-line chemotherapy after progression in patients with good performance | Michele Orditura Gennaro Galizia Vincenzo Sforza Valentina Gambardella Alessio Fabozzi Maria Maddalena Laterza Francesca Andreozzi Jole Ventriglia Beatrice Savastano Andrea Mabilia Eva Lieto Fortunato Ciardiello Ferdinando De Vita | 2014 | World Journal of Gastroenterology2014，20，7： | 116 |
| 14 | 腹部损伤控制性手术的研究进展显示文摘 | 李德辉 孙备 | 2006 | 中国实用外科杂志2006，26，8： | 66 |
| 15 | 单孔腹腔镜手术的技术瓶颈分析显示文摘 | 徐大华 | 2010 | 中国微创外科杂志2010，10，1： | 69 |
| 16 | 术后镇痛与快速康复外科显示文摘快速康复外科(fast-track surgery,FTS)是指采用一系列经循证医学证实的有效的方法对传统的围术期处理进行改良、优化及组合,以减少手术应激及并发症,从而加速患者术后康复的外科新理念[1],其主要特征为“快速康复”“多学科合作”和“循证”。目前FTS已广泛应用于胃肠外科手术、关节置换术、胸科手术、肝胆外科手术等。在此理念中,术后有效镇痛是关键步骤之一,良好的镇痛模式能减少患者术后应激,减弱术后免疫抑制,加速肠道功能恢复,促进患者早日康复。 | 王立婷 吴安石 | 2015 | 北京医学2015，37，8： | 61 |
| 17 | 《妇科单孔腔镜手术技术专家共识》解读显示文摘中华医学会妇产科分会妇科单孔腹腔镜专家组首次提出妇科单孔腹腔镜手术技术(laparoendoscopic single site surgery,LESS)专家共识,并已正式发表。这将对规范、促进和推动LESS在妇科的应用起到积极作用。笔者对该专家共识进行解读。 | 刘海元 孙大为 张俊吉 陈欣 郎景和 | 2017 | 中华腔镜外科杂志(电子版)2017，10，1： | 72 |
| 18 | 中国加速康复外科围手术期非甾体抗炎药临床应用专家共识显示文摘加速康复外科(enhanced recovery after surgery,ERAS)系指为使患者快速康复,在围手术期采用系列有循证医学证据的优化处理措施,以减轻患者创伤应激,从而减少并发症,缩短住院时间,降低再入院及死亡风险,同时降低医疗费用[1]. | 国家卫生健康委员会医管中心加速康复外科专家委员会 浙江省医师协会临床药师专家委员会 浙江省药学会医院药学专业委员会 饶跃峰 冯智英 王融溶 | 2019 | 中华普通外科杂志2019，34，3： | 65 |
| 19 | Laparoscopic natural orifice specimen extraction-colectomy: A systematic review显示文摘Over the last 20 years, laparoscopic colorectal surgery has shown equal efficacy for benign and malignant colorectal diseases when compared to open surgery. However, a laparoscopic approach reduces postoperative morbidity and shortens hospital stay. In the quest to optimize outcomes after laparoscopic colorectal surgery, reduction of access trauma could be a way to improve recovery. To date, one method to reduce access trauma is natural orifice specimen extraction(NOSE). NOSE aims to reduce access trauma in laparoscopic colorectal surgery. The specimen is delivered via a natural orifice and the anastomosis is created intracorporeally. Different methods are used to extract the specimen and to create a bowel anastomosis. Currently, specimens are delivered transcolonically, transrectally, transanally, or transvaginally. Each of these NOSEprocedures raises specific issues with regard to operative technique and application. The presumed benefits of NOSE-procedures are less pain, lower analgesia requirements, faster recovery, shorter hospital stay, better cosmetic results, and lower incisional hernia rates. Avoidance of extraction site laparotomy is the most important characteristic of NOSE. Concerns associated with the NOSE-technique include bacterial contamination of the peritoneal cavity, inflammatory response, and postoperative outcomes, including postoperative pain and the functional and oncologic outcomes. These issues need to be studied in prospective randomized controlled trials. The aim of this systematic review is to describe the role of NOSE in minimally invasive colorectal surgery. | Albert M Wolthuis Anthony de Buck van Overstraeten André D'Hoore | 2014 | World Journal of Gastroenterology2014，20，36： | 65 |
| 20 | Enhanced recovery after surgery programs hasten recovery after colorectal resections显示文摘Colorectal resection was traditionally associated with significant morbidity and prolonged stay in hospital.Laparoscopic colorectal resection was first described in 1991 as a minimally invasive form of colorectal surgery.It was later on assessed by multiple randomized controlled trials and meta-analysis and was found to be associated with a faster recovery,lower complication rates and a shorter stay in hospital compared with open resection.To assess the effect of enhanced recovery after surgery (ERAS) program on postoperative length of stay after elective colorectal resections,a literature review was conducted,supplemented by the results of 111 ERAS colorectal resections at regional NWS Hospital using a protocol based on the Fast Track approach described by Kehlet in 1999.ERAS has been shown to improve postoperative recovery,reduce length of stay and enhance early return to normal function when compared with traditional colorectal surgical protocols.The role of laparoscopic surgery in colorectal resections within a fast-track (ERAS) program is controversial.The current evidence suggests that within such a program,there is no difference between laparoscopic and open colorectal surgery in terms of postoperative recovery rates or length of hospital stay. | Ned Abraham Sinan Albayati | 2011 | World Journal of Gastrointestinal Surgery2011，3，1： | 56 |
您所在的机构暂未开通此部分的功能，请联系管理员